Hirtshals Fysioterapi ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 2.6% 2.6% 2.7% 3.7%  
Credit score (0-100)  0 61 60 60 51  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 1,939 2,026 2,006 1,962  
EBITDA  0.0 1,122 1,112 845 714  
EBIT  0.0 675 583 365 272  
Pre-tax profit (PTP)  0.0 540.6 470.3 257.6 89.4  
Net earnings  0.0 419.8 366.3 197.8 69.3  
Pre-tax profit without non-rec. items  0.0 541 470 258 89.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 6,638 6,304 5,604 5,391  
Shareholders equity total  0.0 1,529 1,782 1,866 1,935  
Interest-bearing liabilities  0.0 4,900 4,223 3,503 3,174  
Balance sheet total (assets)  0.0 7,010 6,591 5,854 5,588  

Net Debt  0.0 4,896 4,222 3,501 3,172  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,939 2,026 2,006 1,962  
Gross profit growth  0.0% 0.0% 4.5% -1.0% -2.2%  
Employees  0 2 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 7,010 6,591 5,854 5,588  
Balance sheet change%  0.0% 0.0% -6.0% -11.2% -4.5%  
Added value  0.0 1,121.8 1,112.3 894.2 714.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 6,431 -923 -1,240 -716  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 34.8% 28.8% 18.2% 13.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 9.6% 8.6% 5.9% 4.8%  
ROI %  0.0% 10.3% 9.2% 6.3% 5.1%  
ROE %  0.0% 27.5% 22.1% 10.8% 3.6%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 21.8% 27.0% 31.9% 34.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 436.5% 379.6% 414.3% 444.1%  
Gearing %  0.0% 320.5% 236.9% 187.8% 164.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 5.5% 2.5% 2.8% 5.5%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.1 0.0 0.1 0.1  
Current Ratio  0.0 0.1 0.0 0.1 0.1  
Cash and cash equivalent  0.0 4.0 1.5 2.0 1.9  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -1,768.4 -2,117.0 -1,695.7 -1,400.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 561 556 447 357  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 561 556 423 357  
EBIT / employee  0 337 292 183 136  
Net earnings / employee  0 210 183 99 35